Computational Prediction of Elbasvir as a Theoretical Candidate for PFOS-Associated Gut and Skin Shared Pathologies
Year: 2026
Type: article
Abstract: Atopic dermatitis (AD) and inflammatory bowel disease (IBD) frequently co-occur along the gut–skin axis, yet the systemic triggers, particularly environmental endocrine-disrupting chemicals like perfluorooctanesulfonic acid (PFOS), remain poorly understood. Here, we integrate network toxicology and single-cell multi-omics to propose a computational framework for the shared molecular signatures of PFOS-driven AD and IBD comorbidity. Utilizing large-scale clinical transcriptomic cohorts and machine learning, we computationally predicted the transcription factor MYC as a potential core pathological hub. Single-cell transcriptomics and in silico virtual perturbation models revealed that aberrant MYC activation is highly restricted to barrier-forming cells: epidermal keratinocytes and intestinal mucosal progenitors. This spatially specific dysregulation not only compromises epithelial structural integrity but also reshapes local chemotactic networks, driving macrophage pro-inflammatory polarization and immune imbalance. To translate these findings, high-throughput drug repurposing screening and 200 ns all-atom molecular dynamics simulations identified the antiviral drug Elbasvir as a stable, high-affinity MYC inhibitor. Collectively, our work proposes a single-cell spatial pathology of environment-driven shared pathologies across the gut–skin axis and provides a theoretical pharmacological strategy to intervene in systemic inflammatory networks.
Source: Toxics
Language: English
Subfield: Environmental Chemistry
Field: Environmental Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7236849628
